Arkolith/Insider Trading/CYCC/Form 4

Barker Sam L

DirectorCyclacel Pharmaceuticals, Inc. (CYCC) · full profile →Form 4 · filed Dec 2, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$43
Net Open-Market Flow
-$43
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 30, 2021Sell(S)12$3.57$433K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-145913) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML